Goldman Sachs
YTEN

Goldman Sachs’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History

Goldman Sachs’s Portfolio YTEN Stock Details YTEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-6
Closed -$21K – 7030
2017
Q1 		$21K Hold
6
– – ﹤0.01% 6504
2016
Q4 		$21K Buy
+6
New +$23K ﹤0.01% 6632
2015
Q2 		– Sell
-1
Closed -$29K – 7477
2015
Q1 		$29K Hold
1
– – ﹤0.01% 6841
2014
Q4 		$19K Hold
1
– – ﹤0.01% 6994
2014
Q3 		$40K Buy
+1
New +$43.2K ﹤0.01% 6880

Other funds holding YTEN

BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PSC
Prentiss Smith & Co Brattleboro, Vermont $182M AUM 26.44% 1-Year Est. Return
TWA
TCI Wealth Advisors Tucson, Arizona $2.31B AUM 26.52% 1-Year Est. Return

Goldman Sachs's YTEN Position: Q2 2017 in Review

Goldman Sachs sold out of Yield10 Bioscience, Inc. Common Stock (YTEN) in Q2 2017, closing a stake of 6 shares — an estimated $21K sold.

Goldman Sachs first reported a position in YTEN in Q3 2014 and held it in 5 quarters. The position peaked at $40K in Q3 2014. 5 funds tracked by Wall St. Rank hold YTEN as of Q2 2017.

  • Goldman Sachs reported no remaining Yield10 Bioscience, Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
  • Goldman Sachs sold 6 Yield10 Bioscience, Inc. Common Stock shares in Q2 2017, an estimated $21K.
  • Goldman Sachs first reported a position in Yield10 Bioscience, Inc. Common Stock in Q3 2014 and held it in 5 quarters.
  • Goldman Sachs's Yield10 Bioscience, Inc. Common Stock position peaked at $40K in Q3 2014.
  • 5 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q2 2017.

Based on Goldman Sachs's 13F filing for Q2 2017, filed 14 Aug 2017.